File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/sj.bjp.0707327
- Scopus: eid_2-s2.0-34547602966
- PMID: 17558433
- WOS: WOS:000248442100009
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Modulation by simvastatin of iberiotoxin-sensitive, Ca 2+- activated K + channels of porcine coronary artery smooth muscle cells
Title | Modulation by simvastatin of iberiotoxin-sensitive, Ca 2+- activated K + channels of porcine coronary artery smooth muscle cells |
---|---|
Authors | |
Keywords | BK Ca channels Coronary artery HMG CoA reductase Simvastatin |
Issue Date | 2007 |
Publisher | John Wiley & Sons Ltd. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=0007-1188&site=1 |
Citation | British Journal Of Pharmacology, 2007, v. 151 n. 7, p. 987-997 How to Cite? |
Abstract | Background and Purpose: Statins (3-hydroxy-3-methyl-glutaryl coenzyme A (HMG CoA) reductase inhibitors) have been demonstrated to reduce cardiovascular mortality. It is unclear how the expression level of HMG CoA reductase in cardiovascular tissues compares with that in cells derived from the liver. We hypothesized that this enzyme exists in different cardiovascular tissues, and simvastatin modulates the vascular iberiotoxin-sensitive Ca 2+- activated K + (BK Ca) channels. Experimental Approaches: Expression of HMG CoA reductase in different cardiovascular preparations was measured. Effects of simvastatin on BK Ca channel gatings of porcine coronary artery smooth muscle cells were evaluated. Key Results: Western immunoblots revealed the biochemical existence of HMG CoA reductase in human cardiovascular tissues and porcine coronary artery. In porcine coronary artery smooth muscle cells, extracellular simvastatin (1, 3 and 10 μM) (hydrophobic), but not simvastatin Na + (hydrophilic), inhibited the BK Ca channels with a minimal recovery upon washout. Isopimaric acid (10 μM)-mediated enhancement of the BK Ca amplitude was reversed by external simvastatin. Simvastatin Na + (10 μM, applied internally), markedly attenuated isopimaric acid (10 μM)-induced enhancement of the BK Ca amplitude. Reduced glutathione (5 mM; in the pipette solution) abolished simvastatin -elicited inhibition. Mevalonolactone (500 μM) and geranylgeranyl pyrophosphate (20 μM) only prevented simvastatin (1 and 3 μM)-induced responses. simvastatin (10 μM) caused a rottlerin (1 μM)-sensitive (cycloheximide (10 μM)-insensitive) increase of PKC-δ protein expression. Conclusions and Implications: Our results demonstrated the biochemical presence of HMG CoA reductase in different cardiovascular tissues, and that simvastatin inhibited the BK Ca channels of the arterial smooth muscle cells through multiple intracellular pathways. © 2007 Nature Publishing Group All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/171357 |
ISSN | 2023 Impact Factor: 6.8 2023 SCImago Journal Rankings: 2.119 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seto, SW | en_US |
dc.contributor.author | Au, ALS | en_US |
dc.contributor.author | Lam, TY | en_US |
dc.contributor.author | Chim, SSC | en_US |
dc.contributor.author | Lee, SMY | en_US |
dc.contributor.author | Wan, S | en_US |
dc.contributor.author | Tjiu, DCS | en_US |
dc.contributor.author | Shigemura, N | en_US |
dc.contributor.author | Yim, APC | en_US |
dc.contributor.author | Chan, SW | en_US |
dc.contributor.author | Tsui, SKW | en_US |
dc.contributor.author | Leung, GPH | en_US |
dc.contributor.author | Kwan, YW | en_US |
dc.date.accessioned | 2012-10-30T06:13:34Z | - |
dc.date.available | 2012-10-30T06:13:34Z | - |
dc.date.issued | 2007 | en_US |
dc.identifier.citation | British Journal Of Pharmacology, 2007, v. 151 n. 7, p. 987-997 | en_US |
dc.identifier.issn | 0007-1188 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171357 | - |
dc.description.abstract | Background and Purpose: Statins (3-hydroxy-3-methyl-glutaryl coenzyme A (HMG CoA) reductase inhibitors) have been demonstrated to reduce cardiovascular mortality. It is unclear how the expression level of HMG CoA reductase in cardiovascular tissues compares with that in cells derived from the liver. We hypothesized that this enzyme exists in different cardiovascular tissues, and simvastatin modulates the vascular iberiotoxin-sensitive Ca 2+- activated K + (BK Ca) channels. Experimental Approaches: Expression of HMG CoA reductase in different cardiovascular preparations was measured. Effects of simvastatin on BK Ca channel gatings of porcine coronary artery smooth muscle cells were evaluated. Key Results: Western immunoblots revealed the biochemical existence of HMG CoA reductase in human cardiovascular tissues and porcine coronary artery. In porcine coronary artery smooth muscle cells, extracellular simvastatin (1, 3 and 10 μM) (hydrophobic), but not simvastatin Na + (hydrophilic), inhibited the BK Ca channels with a minimal recovery upon washout. Isopimaric acid (10 μM)-mediated enhancement of the BK Ca amplitude was reversed by external simvastatin. Simvastatin Na + (10 μM, applied internally), markedly attenuated isopimaric acid (10 μM)-induced enhancement of the BK Ca amplitude. Reduced glutathione (5 mM; in the pipette solution) abolished simvastatin -elicited inhibition. Mevalonolactone (500 μM) and geranylgeranyl pyrophosphate (20 μM) only prevented simvastatin (1 and 3 μM)-induced responses. simvastatin (10 μM) caused a rottlerin (1 μM)-sensitive (cycloheximide (10 μM)-insensitive) increase of PKC-δ protein expression. Conclusions and Implications: Our results demonstrated the biochemical presence of HMG CoA reductase in different cardiovascular tissues, and that simvastatin inhibited the BK Ca channels of the arterial smooth muscle cells through multiple intracellular pathways. © 2007 Nature Publishing Group All rights reserved. | en_US |
dc.language | eng | en_US |
dc.publisher | John Wiley & Sons Ltd. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=0007-1188&site=1 | en_US |
dc.relation.ispartof | British Journal of Pharmacology | en_US |
dc.subject | BK Ca channels | - |
dc.subject | Coronary artery | - |
dc.subject | HMG CoA reductase | - |
dc.subject | Simvastatin | - |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Blotting, Western | en_US |
dc.subject.mesh | Caveolin 1 - Biosynthesis | en_US |
dc.subject.mesh | Cell Line | en_US |
dc.subject.mesh | Cell Line, Tumor | en_US |
dc.subject.mesh | Coronary Vessels - Cytology - Drug Effects - Physiology | en_US |
dc.subject.mesh | Dose-Response Relationship, Drug | en_US |
dc.subject.mesh | Enzyme Activation - Drug Effects | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hydroxymethylglutaryl-Coa Reductase Inhibitors - Pharmacology | en_US |
dc.subject.mesh | Imidazoles - Pharmacology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Membrane Potentials - Drug Effects | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Muscle, Smooth, Vascular - Cytology - Drug Effects - Physiology | en_US |
dc.subject.mesh | Myocytes, Smooth Muscle - Drug Effects - Metabolism - Physiology | en_US |
dc.subject.mesh | Peptides - Pharmacology | en_US |
dc.subject.mesh | Phorbol Esters - Pharmacology | en_US |
dc.subject.mesh | Potassium Channels, Calcium-Activated - Antagonists & Inhibitors - Metabolism - Physiology | en_US |
dc.subject.mesh | Protein Kinase C-Delta - Metabolism | en_US |
dc.subject.mesh | Pyridines - Pharmacology | en_US |
dc.subject.mesh | Simvastatin - Chemistry - Pharmacology | en_US |
dc.subject.mesh | Swine | en_US |
dc.title | Modulation by simvastatin of iberiotoxin-sensitive, Ca 2+- activated K + channels of porcine coronary artery smooth muscle cells | en_US |
dc.type | Article | en_US |
dc.identifier.email | Leung, GPH:gphleung@hkucc.hku.hk | en_US |
dc.identifier.authority | Leung, GPH=rp00234 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1038/sj.bjp.0707327 | en_US |
dc.identifier.pmid | 17558433 | - |
dc.identifier.scopus | eid_2-s2.0-34547602966 | en_US |
dc.identifier.hkuros | 157508 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-34547602966&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 151 | en_US |
dc.identifier.issue | 7 | en_US |
dc.identifier.spage | 987 | en_US |
dc.identifier.epage | 997 | en_US |
dc.identifier.isi | WOS:000248442100009 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Seto, SW=9941482400 | en_US |
dc.identifier.scopusauthorid | Au, ALS=7005391144 | en_US |
dc.identifier.scopusauthorid | Lam, TY=18134321000 | en_US |
dc.identifier.scopusauthorid | Chim, SSC=6701728226 | en_US |
dc.identifier.scopusauthorid | Lee, SMY=35233892600 | en_US |
dc.identifier.scopusauthorid | Wan, S=7202724268 | en_US |
dc.identifier.scopusauthorid | Tjiu, DCS=18134494600 | en_US |
dc.identifier.scopusauthorid | Shigemura, N=36966937200 | en_US |
dc.identifier.scopusauthorid | Yim, APC=7102593653 | en_US |
dc.identifier.scopusauthorid | Chan, SW=7404255670 | en_US |
dc.identifier.scopusauthorid | Tsui, SKW=7004961364 | en_US |
dc.identifier.scopusauthorid | Leung, GPH=35963668200 | en_US |
dc.identifier.scopusauthorid | Kwan, YW=7005662153 | en_US |
dc.identifier.issnl | 0007-1188 | - |